In keeping with our findings, MSI2 loss-of-function or silencing abrogates cell growth and induces apoptosis in several tissues [20, 55, 56] and in AML and CML cell lines [10, 44, 57] as well as in primary AML cells [58]. Here, MSI2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.